Stage IV Lung Cancer Patient Story
This lung cancer diagnosis at a glance
- Stage at diagnosis
- Stage IV
- Spread to
- spine/bones, including T11 vertebra
- Treatment
- targeted therapy
- Outcome
- Responding Well
Treatment course, step by step
- An unnamed targeted medication with minimal side effects that shrank all tumors.
What happened, in summary
At age 30, while completing an oral and maxillofacial surgery residency, the patient developed worsening back pain, muscle spasms, difficulty walking, and numbness in the legs. An emergency MRI showed lesions throughout the spine and a compression fracture at the T11 vertebra. Additional imaging found a lesion in the left upper lobe of the lung and enlarged lymph nodes in the chest. Because the cancer had spread to the spine, the diagnosis was Stage IV lung cancer.
The diagnosis forced an immediate change in priorities. The patient worried about the family, including a wife and their 15-week-old daughter, and whether the residency could ever be completed. An unnamed targeted medication produced a major response, shrinking all the tumors while causing minimal side effects. As the response continued, returning to work became possible again.
Being both a physician and a patient changed the approach to care. The patient kept detailed records, learned about treatment advances, and connected with other people living with lung cancer. The experience strengthened the belief that patients need to understand their disease and actively coordinate their own care. Seeing long-term survivors also helped replace the assumption of an immediate death sentence with a more hopeful view of life with Stage IV cancer.
Where this story comes from
This is a lay summary of an account first published by LUNGevity. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer